Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Hurley Medical Center
mi
from
Flint, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Van Elslander Cancer Center at St. John Hospital and Medical Center
mi
from
Grosse Pointe Woods, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Van Elslander Cancer Center at St. John Hospital and Medical Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Sparrow Regional Cancer Center
mi
from
Lansing, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Sparrow Regional Cancer Center
mi
from
Lansing, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Mary Mercy Hospital
mi
from
Livonia, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Community Cancer Center of Monroe
mi
from
Monroe, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Community Cancer Center of Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mercy Regional Cancer Center at Mercy Hospital
mi
from
Port Huron, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mercy Regional Cancer Center at Mercy Hospital
mi
from
Port Huron, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Seton Cancer Institute at Saint Mary's - Saginaw
mi
from
Saginaw, MI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Seton Cancer Institute at Saint Mary's - Saginaw
mi
from
Saginaw, MI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
mi
from
Columbia, MO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Creighton University Medical Center
mi
from
Omaha, NE
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Immanuel Medical Center
mi
from
Omaha, NE
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Lakeside Hospital
mi
from
Omaha, NE
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Monter Cancer Center of the North Shore-LIJ Health System
mi
from
Lake Success, NY
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Monter Cancer Center of the North Shore-LIJ Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Don Monti Comprehensive Cancer Center at North Shore University Hospital
mi
from
Manhasset, NY
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Don Monti Comprehensive Cancer Center at North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Randolph Hospital
mi
from
Asheboro, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Randolph Hospital
mi
from
Asheboro, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Presbyterian Cancer Center at Presbyterian Hospital
mi
from
Charlotte, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Presbyterian Cancer Center at Presbyterian Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Moses Cone Regional Cancer Center at Wesley Long Community Hospital
mi
from
Greensboro, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Moses Cone Regional Cancer Center at Wesley Long Community Hospital
mi
from
Greensboro, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Pardee Memorial Hospital
mi
from
Hendersonville, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Kinston Medical Specialists
mi
from
Kinston, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Annie Penn Cancer Center
mi
from
Reidsville, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Annie Penn Cancer Center
mi
from
Reidsville, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Community Cancer Center
mi
from
Elyria, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Community Cancer Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Hematology Oncology Center
mi
from
Elyria, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Hematology Oncology Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Lima Memorial Hospital
mi
from
Lima, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Lima Memorial Hospital
mi
from
Lima, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Toledo Clinic - Oregon
mi
from
Oregon, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Toledo Clinic - Oregon
mi
from
Oregon, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Toledo Clinic, Incorporated - Main Clinic
mi
from
Toledo, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Toledo Clinic, Incorporated - Main Clinic
mi
from
Toledo, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Anne Mercy Hospital
mi
from
Toledo, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Anne Mercy Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Toledo Hospital
mi
from
Toledo, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Fulton County Health Center
mi
from
Wauseon, OH
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Fulton County Health Center
mi
from
Wauseon, OH
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Geisinger Cancer Institute at Geisinger Health
mi
from
Danville, PA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Geisinger Cancer Institute at Geisinger Health
mi
from
Danville, PA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Geisinger Hazleton Cancer Center
mi
from
Hazleton, PA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Geisinger Hazleton Cancer Center
mi
from
Hazleton, PA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Oncology Services of Aberdeen
mi
from
Aberdeen, SD
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Oncology Services of Aberdeen
mi
from
Aberdeen, SD
Click here to add this to my saved trials